Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Juan Macías

Showing results (1-10 of 161) with videos related to

Pageof 17
Sort By:
Enfermedades Infecciosas Y Microbiologia Clinica|September 26, 2013
[Safety and efficacy of telaprevir in patients with HIV and hepatitis C virus coinfection]Juan Macías, Antonio Rivero
The Journal of Antimicrobial Chemotherapy|February 26, 2005
Progression of liver fibrosis in patients coinfected with hepatitis C virus and human immunodeficiency virus undergoing antiretroviral therapyJuan A Pineda, Juan Macías
AIDS Reviews|February 10, 2017
Non-Alcoholic Fatty Liver Disease in HIV InfectionJuan Macías, Juan A Pineda, Luis M Real
Expert Opinion on Pharmacotherapy|August 3, 2014
Latest pharmacotherapy options for treating hepatitis C in HIV-infected patientsJuan Macías, Karin Neukam, Nicolás Merchante, et al.
Current Opinion in HIV and AIDS|September 16, 2011
Host geneticsJuan Macías, Eugenia Vispo, Juan A Pineda, et al.
Expert Opinion on Pharmacotherapy|February 5, 2009
A review of current anti-HCV treatment regimens and possible future strategiesKarin Neukam, Juan Macías, José A Mira, et al.
Medicina Clinica|November 8, 2002
[Prevalence of Bartonella spp. seropositivity in human immunodeficiency virus-infected and non infected intravenous drug abusers]Antonio J Ramos, Julio Vargas, Javier Fernández-Rivera, et al.
Journal of Hepatology|September 20, 2016
HCV epidemiology in high-risk groups and the risk of reinfectionHåvard Midgard, Amanda Weir, Norah Palmateer, et al.
Medicina Clinica|April 30, 2003
[Kinetics of Bartonella spp. IgG antibodies in cat-scratch disease and in asymptomatic HIV-infected patients]José Angel García-García, Julio Vargas, José Antonio Mira, et al.
HIV Clinical Trials|September 3, 2009
Impact of observer experience on the reproducibility of transient elastometry in HIV/HCV co-infected patientsKarin Neukam, Juan Macías, Concepción Ferrete, et al.
Pageof 17

Showing results (1-10 of 161) with videos related to

Sort By:
Pageof 17
Enfermedades Infecciosas Y Microbiologia Clinica|September 26, 2013
[Safety and efficacy of telaprevir in patients with HIV and hepatitis C virus coinfection]Juan Macías, Antonio Rivero
The Journal of Antimicrobial Chemotherapy|February 26, 2005
Progression of liver fibrosis in patients coinfected with hepatitis C virus and human immunodeficiency virus undergoing antiretroviral therapyJuan A Pineda, Juan Macías
AIDS Reviews|February 10, 2017
Non-Alcoholic Fatty Liver Disease in HIV InfectionJuan Macías, Juan A Pineda, Luis M Real
Expert Opinion on Pharmacotherapy|August 3, 2014
Latest pharmacotherapy options for treating hepatitis C in HIV-infected patientsJuan Macías, Karin Neukam, Nicolás Merchante, et al.
Current Opinion in HIV and AIDS|September 16, 2011
Host geneticsJuan Macías, Eugenia Vispo, Juan A Pineda, et al.
Expert Opinion on Pharmacotherapy|February 5, 2009
A review of current anti-HCV treatment regimens and possible future strategiesKarin Neukam, Juan Macías, José A Mira, et al.
Medicina Clinica|November 8, 2002
[Prevalence of Bartonella spp. seropositivity in human immunodeficiency virus-infected and non infected intravenous drug abusers]Antonio J Ramos, Julio Vargas, Javier Fernández-Rivera, et al.
Journal of Hepatology|September 20, 2016
HCV epidemiology in high-risk groups and the risk of reinfectionHåvard Midgard, Amanda Weir, Norah Palmateer, et al.
Medicina Clinica|April 30, 2003
[Kinetics of Bartonella spp. IgG antibodies in cat-scratch disease and in asymptomatic HIV-infected patients]José Angel García-García, Julio Vargas, José Antonio Mira, et al.
HIV Clinical Trials|September 3, 2009
Impact of observer experience on the reproducibility of transient elastometry in HIV/HCV co-infected patientsKarin Neukam, Juan Macías, Concepción Ferrete, et al.
Pageof 17